Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHCO NASDAQ:OPCH NASDAQ:SHC NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$9.37+1.5%$9.17$7.11▼$11.63$1.27B1.61779,321 shs705,406 shsOPCHOption Care Health$27.91-0.5%$27.99$21.39▼$35.53$4.53B0.881.68 million shs1.10 million shsSHCSotera Health$16.86-0.2%$16.09$9.53▼$17.15$4.79B1.821.30 million shs1.04 million shsWGSGeneDx$128.87+3.0%$123.22$55.17▼$136.00$3.70B1.98473,654 shs482,810 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth0.00%+2.52%+7.33%-0.74%-11.85%OPCHOption Care Health0.00%+0.50%+4.06%-6.00%-7.12%SHCSotera Health0.00%+4.33%+8.49%+37.07%+8.77%WGSGeneDx0.00%+6.56%+14.08%+61.43%+129.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$9.37+1.5%$9.17$7.11▼$11.63$1.27B1.61779,321 shs705,406 shsOPCHOption Care Health$27.91-0.5%$27.99$21.39▼$35.53$4.53B0.881.68 million shs1.10 million shsSHCSotera Health$16.86-0.2%$16.09$9.53▼$17.15$4.79B1.821.30 million shs1.04 million shsWGSGeneDx$128.87+3.0%$123.22$55.17▼$136.00$3.70B1.98473,654 shs482,810 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth0.00%+2.52%+7.33%-0.74%-11.85%OPCHOption Care Health0.00%+0.50%+4.06%-6.00%-7.12%SHCSotera Health0.00%+4.33%+8.49%+37.07%+8.77%WGSGeneDx0.00%+6.56%+14.08%+61.43%+129.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHCOAdaptHealth 2.43Hold$13.4043.01% UpsideOPCHOption Care Health 2.69Moderate Buy$35.1025.76% UpsideSHCSotera Health 2.50Moderate Buy$17.202.02% UpsideWGSGeneDx 2.58Moderate Buy$112.80-12.47% DownsideCurrent Analyst Ratings BreakdownLatest AHCO, SHC, OPCH, and WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/25/2025OPCHOption Care HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/24/2025AHCOAdaptHealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/24/2025WGSGeneDxWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/22/2025WGSGeneDxBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$125.00 ➝ $140.0010/20/2025WGSGeneDxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$155.0010/20/2025WGSGeneDxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$155.0010/17/2025OPCHOption Care HealthMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$35.0010/8/2025AHCOAdaptHealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/8/2025OPCHOption Care HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/8/2025SHCSotera HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/8/2025WGSGeneDxWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)(Data available from 10/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHCOAdaptHealth$3.26B0.39$3.79 per share2.47$11.72 per share0.80OPCHOption Care Health$5.00B0.91$1.64 per share16.97$8.25 per share3.38SHCSotera Health$1.12B4.26$1.20 per share14.04$1.43 per share11.79WGSGeneDx$305.45M12.12$1.02 per share125.94$8.75 per share14.73Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHCOAdaptHealth$90.42M$0.5417.359.661.162.49%5.01%1.77%11/4/2025 (Estimated)OPCHOption Care Health$211.82M$1.2522.3322.151.693.93%17.53%7.17%10/30/2025 (Estimated)SHCSotera Health$44.34M$0.08210.7824.09N/A2.14%39.42%5.66%11/4/2025 (Estimated)WGSGeneDx-$52.29M$0.052,577.4061.66N/A0.39%16.51%9.35%10/28/2025 (Estimated)Latest AHCO, SHC, OPCH, and WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/4/2025Q3 2025AHCOAdaptHealth$0.27N/AN/AN/A$799.62 millionN/A11/4/2025Q3 2025SHCSotera Health$0.22N/AN/AN/A$303.63 millionN/A10/30/2025Q3 2025OPCHOption Care Health$0.43N/AN/AN/A$1.41 billionN/A10/28/2025Q3 2025WGSGeneDx$0.33N/AN/AN/A$104.33 millionN/A8/8/2025Q2 2025SHCSotera Health$0.17$0.20+$0.03$0.03$275.81 million$294.34 million7/30/2025Q2 2025OPCHOption Care Health$0.40$0.41+$0.01$0.31$1.35 billion$1.42 billion7/29/2025Q2 2025WGSGeneDx$0.10$0.50+$0.40$0.36$86.00 million$102.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAHCOAdaptHealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ASHCSotera HealthN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAHCOAdaptHealth1.141.060.82OPCHOption Care Health0.811.521.00SHCSotera Health4.492.472.23WGSGeneDx0.192.872.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHCOAdaptHealth82.67%OPCHOption Care Health98.05%SHCSotera Health91.03%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipAHCOAdaptHealth1.55%OPCHOption Care Health0.64%SHCSotera Health47.55%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHCOAdaptHealth10,500135.30 million133.20 millionOptionableOPCHOption Care Health8,088162.29 million161.26 millionOptionableSHCSotera Health3,000284.05 million148.98 millionOptionableWGSGeneDx1,20028.73 million20.22 millionOptionableAHCO, SHC, OPCH, and WGS HeadlinesRecent News About These CompaniesVIRGINIA RETIREMENT SYSTEMS ET Al Takes Position in GeneDx Holdings Corp. $WGS1 hour ago | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Given Consensus Rating of "Moderate Buy" by Brokerages3 hours ago | marketbeat.comGeneDx (NASDAQ:WGS) Receives Sell (D) Rating from Weiss RatingsOctober 25 at 6:43 PM | marketbeat.comAllspring Global Investments Holdings LLC Sells 184,306 Shares of GeneDx Holdings Corp. $WGSOctober 25 at 3:38 AM | marketbeat.comHalper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their RightsOctober 24 at 9:40 AM | businesswire.comAnalysts Are Bullish on Top Healthcare Stocks: Simulations Plus (SLP), GeneDx Holdings (WGS)October 23 at 9:57 AM | theglobeandmail.comBTIG Maintains GeneDx Holdings (WGS) Buy RecommendationOctober 23 at 4:56 AM | msn.comGeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025October 22, 2025 | finance.yahoo.comGeneDx (NASDAQ:WGS) Upgraded by Canaccord Genuity Group to Strong-Buy RatingOctober 22, 2025 | marketbeat.comBTIG Research Increases GeneDx (NASDAQ:WGS) Price Target to $140.00October 22, 2025 | marketbeat.com4 Analysts Assess GeneDx Holdings: What You Need To KnowOctober 21, 2025 | benzinga.comGeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ TestingOctober 21, 2025 | theglobeandmail.comGeneDx (WGS) Projected to Post Earnings on TuesdayOctober 21, 2025 | marketbeat.comTD Asset Management Inc Boosts Position in GeneDx Holdings Corp. $WGSOctober 21, 2025 | marketbeat.comGeneDx initiated with a Buy at CanaccordOctober 20, 2025 | msn.comWilliam Blair Investment Management LLC Acquires 442,414 Shares of GeneDx Holdings Corp. $WGSOctober 18, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Stock Price Up 5% - Here's What HappenedOctober 17, 2025 | marketbeat.comWGS, PONY, QSI, SLMT: Cathie Wood Snaps Up Biotech and AI Stocks, Trims Stake in a Semiconductor NameOctober 17, 2025 | msn.comAberdeen Group plc Acquires New Position in GeneDx Holdings Corp. $WGSOctober 16, 2025 | marketbeat.comGeneDX CEO Katherine Stueland on how the company is using AI to save livesOctober 15, 2025 | youtube.comYGeneDX CEO Katherine Stueland on conquering imposter syndromeOctober 15, 2025 | youtube.comYNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAHCO, SHC, OPCH, and WGS Company DescriptionsAdaptHealth NASDAQ:AHCO$9.37 +0.14 (+1.52%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$9.44 +0.07 (+0.75%) As of 10/24/2025 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Option Care Health NASDAQ:OPCH$27.91 -0.13 (-0.46%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$27.91 0.00 (0.00%) As of 10/24/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.Sotera Health NASDAQ:SHC$16.86 -0.04 (-0.24%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$16.86 0.00 (-0.03%) As of 10/24/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.GeneDx NASDAQ:WGS$128.87 +3.80 (+3.04%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$129.73 +0.86 (+0.67%) As of 10/24/2025 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 10/20 - 10/24 Freeport-McMoRan Posts Strong Earnings Despite Indonesia Shutdown Tractor Supply Stock Looks Like a Buy-and-Hold Winner Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Fal.Con Europe Could Be CrowdStrike’s Early Earnings Catalyst Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% Upside Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
